Chesnut, C H <br/><br/>
Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass.  [electronic resource] 

 -  Metabolism: clinical and experimental  Mar 1977 
 - 267-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1016/0026-0495(77)90073-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Body Composition--drug effects<br/>Bone and Bones--analysis<br/>Calcium--analysis<br/>Clinical Trials as Topic<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Menopause<br/>Methandrostenolone--therapeutic use<br/>Middle Aged<br/>Neutron Activation Analysis<br/>Osteoporosis--drug therapy<br/>Placebos